Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 2.63 +0.18 (7.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.45 | 52 Week High | $21.49 | |||
| Open | $2.48 | 52 Week Low | $15.75 | |||
| Day High | $2.70 | P/E | 2.99 | |||
| Day Low | $2.45 | EPS | $0.88 | |||
| Volume | 324,221 | |||||
